NCT03750669 2025-05-13
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 3 Completed
Second Affiliated Hospital, School of Medicine, Zhejiang University
University Hospital, Essen
AIO-Studien-gGmbH
Liaoning Cancer Hospital & Institute
Lithuanian University of Health Sciences
Dartmouth-Hitchcock Medical Center
AIO-Studien-gGmbH
Shanghai Jiao Tong University School of Medicine
Taichung Veterans General Hospital
Roswell Park Cancer Institute